| Christiana Araniz, LPN | |
|
23 N Main St, Attleboro, MA 02703-2217 | |
| (508) 342-8041 | |
| (508) 342-8042 |
| Full Name | Christiana Araniz |
|---|---|
| Gender | Female |
| Speciality | Licensed Practical Nurse |
| Location | 23 N Main St, Attleboro, Massachusetts |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144801242 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164W00000X | Licensed Practical Nurse | LN98672 (Massachusetts) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Christiana Araniz, LPN 23 N Main St, Attleboro, MA 02703-2217 Ph: (508) 342-8041 | Christiana Araniz, LPN 23 N Main St, Attleboro, MA 02703-2217 Ph: (508) 342-8041 |
News Archive
Omega-3 polyunsaturated fats (PUFAs) found in seafood may reduce arterial stiffness and improve heart function in chronic heart failure, according to new research. These fats, better known as EPA and DHA, may also help in the immediate aftermath of a stroke.
In a new paper published in the Harvard Kennedy School Misinformation Review, researchers from the George Washington University, University of Maryland and Johns Hopkins University assessed content from the most active vaccine-related accounts on Twitter and found that even accounts with pro-vaccination views and higher public health credibility can be vectors of misinformation in the highly uncertain and rapidly changing environment caused by the COVID-19 pandemic.
XenoPort, Inc. announced today that it has initiated a Phase 2b clinical trial of arbaclofen placarbil (AP), also known as XP19986, in patients with gastroesophageal reflux disease (GERD) who remain symptomatic despite treatment with a proton pump inhibitor (PPI). The trial is a multi-center, randomized, double-blind, placebo-controlled study designed to assess the efficacy and safety of AP as adjunctive therapy to PPIs.
Weill Cornell Medical College today celebrated the start of construction on its new Medical Research Building, a state-of-the-art facility that will more than double the institution's existing research space. The 18-story, $650 million building is the centerpiece of Weill Cornell's $1.3 billion Discoveries that Make a Difference Campaign, the country's largest for a medical college. A total of $1 billion has been raised toward this goal in a record time of less than four years.
The U.S. Food and Drug Administration announced today that it has scheduled a public meeting on Feb. 18, 2010, to discuss key challenges related to the premarket notification, or 510(k) process, used to review and clear certain medical devices marketed in the United States. The FDA receives more than 3,000 510(k) submissions each year.
› Verified 3 days ago
Evelyn Chacon, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 10 Oakland Ave Apt 1, Attleboro, MA 02703 Phone: 774-719-3744 | |
Suzanne Mara Mello, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 23 N Main St, Attleboro, MA 02703 Phone: 508-342-8041 | |
Sharon Alfred, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 50 Chapel Hill Dr, Attleboro, MA 02703 Phone: 508-965-7875 | |
Valerie Joseph, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 7 Railroad Ave Unit B, Attleboro, MA 02703 Phone: 833-510-4357 | |
Mr. Moses N Mwangi, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 50 Maynard St Apt 117, Attleboro, MA 02703 Phone: 508-369-3229 | |
Kelly Pouliot, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 25 N Main St, Attleboro, MA 02703 Phone: 508-436-5531 |